These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21045690)

  • 21. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutations of tumor suppressor gemne TP53 in tobacco smoke-associated tumors].
    Szyfter K; Kiwerska K; Rydzanicz M; Kruszyna Ł; Zemleduch T; Jagodziński P
    Przegl Lek; 2009; 66(10):603-7. PubMed ID: 20301891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
    Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
    Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TP53 in breast cancer development.
    Eeles RA; Bartkova J; Lane DP; Bartek J
    Cancer Surv; 1993; 18():57-75. PubMed ID: 8013000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline mutations in the TP53 gene.
    Eeles RA
    Cancer Surv; 1995; 25():101-24. PubMed ID: 8718514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.
    Bumroongkit K; Rannala B; Traisathit P; Srikummool M; Wongchai Y; Kangwanpong D
    Cancer Genet Cytogenet; 2008 Aug; 185(1):20-7. PubMed ID: 18656689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
    Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
    Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
    Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
    Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
    Børresen-Dale AL; Lothe RA; Meling GI; Hainaut P; Rognum TO; Skovlund E
    Clin Cancer Res; 1998 Jan; 4(1):203-10. PubMed ID: 9516972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
    Geisler S; Børresen-Dale AL; Johnsen H; Aas T; Geisler J; Akslen LA; Anker G; Lønning PE
    Clin Cancer Res; 2003 Nov; 9(15):5582-8. PubMed ID: 14654539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
    Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic variations of the tumor suppressor TP53: outstanding and strategies of analysis].
    Rangel-López A; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(3):254-64. PubMed ID: 16958302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer.
    Wang YC; Chen CY; Wang HJ; Chen SK; Chang YY; Lin P
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):402-10. PubMed ID: 10418172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
    Russo A; Bazan V; Iacopetta B; Kerr D; Soussi T; Gebbia N;
    J Clin Oncol; 2005 Oct; 23(30):7518-28. PubMed ID: 16172461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.